Spero therapeutics to present data at the 32nd european congress of clinical microbiology and infectious diseases

Cambridge, mass., april 21, 2022 (globe newswire) -- spero therapeutics, inc. (nasdaq: spro) today announced two oral presentations and four poster presentations at the 32nd european congress of clinical microbiology and infectious diseases (eccmid) being held april 23-26, 2022, in lisbon, portugal.
SPRO Ratings Summary
SPRO Quant Ranking